New Azalomycin F Analogs from Mangrove Streptomyces Sp. 211726 with Activity Against Microbes and Cancer Cells.

Ganjun Yuan,Kui Hong,Haipeng Lin,Zhigang She,Jia Li
DOI: https://doi.org/10.3390/md11030817
2013-01-01
Marine Drugs
Abstract:Seven new azalomycin F analogs (1-7) were isolated from the broth of mangrove Streptomyces sp. 211726, and respectively identified as 25-malonyl demalonylazalomycin F5a monoester (1), 23-valine demalonylazalomycin F5a ester (2), 23-(6-methyl)heptanoic acid demalonylazalomycins F3a ester (3), F4a ester (4) and F5a ester (5), 23-(9-methyl)decanoic acid demalonylazalomycin F4a ester (6) and 23-(10-methyl)undecanoic acid demalony lazalomycin F4a ester (7). Their structures were established by their spectroscopic data and by comparing with those of azalomycins F3a, F4a and F5a. Biological assays exhibited that 1-7 showed broad-spectrum antimicrobial and anti HCT-116 activities.
What problem does this paper attempt to address?